XFOR
X4 Pharmaceuticals Inc
Biotechnology
X4 Pharmaceuticals Inc (XFOR) Stock News
The latest XFOR headlines and market coverage — 1 recent story, updated throughout the day.
- Benzinga·
OXFORD BANK CORPORATION ANNOUNCES FIRST QUARTER 2026 OPERATING RESULTS
Oxford Bank Corporation reported Q1 2026 net income of $1.53 million ($0.62 per share), down 46% from $2.82 million ($1.15 per share) in Q1 2025. The decline was driven by a $1.5 million credit reserve adjustment on a construction loan and anticipated deposit normalization from a large client. Despite headline earnings weakness, the bank showed strong lending activity, increased net interest income by 11%, and maintained solid capital ratios. Total assets declined to $902.1 million from $1.09 billion due to the expected deposit reduction.